Dr. Jorge Castillo’s (Dana-Farber Cancer Institute) presentation, “Treatment Options in WM,” was recorded and is now available for viewing.
The new non-live vaccine for shingles, Shingrix, has been approved by the FDA and the CDC in the US and by Health Canada for use in patients who are fifty and older.
With a population of just over four million, New Zealand is a small country in numbers of people, but not in land mass.
The IWMF has participated in the Global Patient Survey since 2012. It’s time again to participate & ensure that WM is represented.
Register now to attend the 2018 IWMF Ed Forum and get the latest news regarding treatment and survivorship from top clinicians, researchers, fellow patients, and caregivers!
New Global Patient Database for WM - Your help is needed.
The IWMF is pleased to be able to now provide WM Treatment Fact Sheets in German, and the Frequently Asked Questions Booklet in Finnish.
Daniela Calamai, from Pisa, Italy, shares WM with her mother who has lived with it for almost 30 years.
There is exciting news for WMers in England, and hopeful news for those in Australia, as health agencies have recently approved ibrutinib for WM (England) and CLL/SLL (Australia).
The initial findings from WhiMSICAL, the first-of-its-kind patient- and researcher-led WM database will be presented at upcoming medical conferences. But, we need your help!